News
1d
Zacks Investment Research on MSNRXRX vs. SDGR: Which AI-Powered Drug Discovery Stock Has More Upside?Recursion Pharmaceuticals RXRX and Schrodinger SDGR are pioneering the use of artificial intelligence (AI) in drug discovery ...
Artificial intelligence is gaining ground in healthcare, and tech's biggest players are racing to stake their claims.
Alphabet stock’s pullback from its February ... and an artificial intelligence-powered drug discovery platform called Isomorphic, just to name a few. Many of these experimental efforts may ...
Google parent Alphabet (GOOGL) reported first-quarter revenue and profit that exceeded analysts’ expectations, sending shares higher in extended trading Thursday. The tech titan reported revenue ...
While Isomorphic is an independent unit of Google parent Alphabet, Hassabis' dual roles reflect the intertwined relationship between the two parties. Isomorphic has never revealed how much Google ...
Alphabet stock fell 22.1% in Q1 2025 following disappointing revenue and uncomfortably generous capital spending plans. Some investors see Alphabet's $75 billion capital expense budget as a threat ...
Building on their longstanding partnership, Google, Alphabet and NVIDIA announced new initiatives ... teams from Google DeepMind, Isomorphic Labs, Intrinsic, and X’s moonshot Tapestry will discuss ...
This is the second massive round from an Alphabet/Google spinout this week. Earlier, Isomorphic Labs raised $600 million in its first external funding round as the company looks to apply artificial ...
London-based Isomorphic is an autonomous subsidiary of Alphabet. It came from DeepMind, a different Alphabet subsidiary that uses machine learning to solve problems. Isomorphic was formed in 2021 ...
Isomorphic Labs is a spin-off from Alphabet’s AI research division, Google DeepMind, with many team members involved in developing AlphaFold, an AI model for predicting protein structures. The company ...
aiming to 'reimagine' the entire drug discovery process Isomorphic Labs, a subsidiary of Google parent Alphabet that uses artificial intelligence (AI) for drug discovery, announced on March 31 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results